CALCCalciMedica Inc
$0.7867
$0.0767
(10.80%)
Mkt Cap$21.82M
Vol198,523.00
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program PR Newswire LA JOLLA, Calif., June 24, 2026...
PR Newswire
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data PR Newswire LA JOLLA, Calif., June 24, 2026 FDA...
PR Newswire
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates...
PR Newswire
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates CalciMedica Reports 2025 Financial Results and Provides Clinical Updates PR Newswire LA JOLLA, Calif., March 3, 2026 Internal...
PR Newswire
How Is The Market Feeling About CalciMedica Inc?
read more...
Benzinga
CalciMedica (NASDAQ:CALC) Upgraded to Sell at Wall Street Zen
Wall Street Zen upgraded CalciMedica to a "sell" rating in a report on Saturday...
MarketBeat
CalciMedica (NASDAQ:CALC) Trading Down 2.1% - Time to Sell?
CalciMedica (NASDAQ:CALC) Stock Price Down 2.1% - Time to Sell...
MarketBeat
Stonepine Capital Management LLC Has $136,000 Stock Position in CalciMedica Inc. $CALC
Stonepine Capital Management LLC lowered its stake in shares of CalciMedica Inc. (NASDAQ:CALC - Free Report) by 76.9% during the second quarter, according to the company in its most recent filing...
MarketBeat
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates...
PR Newswire
<
1
2
...
>
Advertisement|Remove ads.
Latest CALC News
ViewCalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program
PR Newswire
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data
PR Newswire
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
PR Newswire
SMCI3
5
RKLB1
3
RDDT3
7Advertisement|Remove ads.